Product NDC: | 10802-1202 |
Proprietary Name: | Ergomar |
Non Proprietary Name: | Ergotamine Tartrate |
Active Ingredient(s): | 2 mg/1 & nbsp; Ergotamine Tartrate |
Administration Route(s): | SUBLINGUAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10802-1202 |
Labeler Name: | Rosedale Therapeutics |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087693 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120831 |
Package NDC: | 10802-1202-3 |
Package Description: | 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, UNIT-DOSE (10802-1202-3) |
NDC Code | 10802-1202-3 |
Proprietary Name | Ergomar |
Package Description | 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, UNIT-DOSE (10802-1202-3) |
Product NDC | 10802-1202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ergotamine Tartrate |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | SUBLINGUAL |
Start Marketing Date | 20120831 |
Marketing Category Name | ANDA |
Labeler Name | Rosedale Therapeutics |
Substance Name | ERGOTAMINE TARTRATE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] |